Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 3b, open-label pilot study to evaluate the safety and effectiveness of up to four treatment cycles of AA4500 in combination with the ErecAid Esteem Manual Vacuum Therapy System in men with Peyronie's disease

Trial Profile

A phase 3b, open-label pilot study to evaluate the safety and effectiveness of up to four treatment cycles of AA4500 in combination with the ErecAid Esteem Manual Vacuum Therapy System in men with Peyronie's disease

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Nov 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Collagenase clostridium histolyticum (Primary)
  • Indications Peyronie's disease
  • Focus Therapeutic Use
  • Sponsors Endo Pharmaceuticals
  • Most Recent Events

    • 17 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 22 Oct 2015 Planned End Date changed from 1 Nov 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.
    • 22 Oct 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top